SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2011 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?


To: BulbaMan who wrote (289)11/18/2011 10:14:45 PM
From: tom pope  Respond to of 400
 
Amazing - I'm beating the median (barely) even though I made the mistake of thinking Chinese biotechs (2 of them) were worth investing in. Unfortunately, I still have one of them (SKBI), tho at a lower price in real life than in the contest.



To: BulbaMan who wrote (289)11/25/2011 6:52:23 PM
From: BulbaMan  Read Replies (1) | Respond to of 400
 
11/25/11 Contest Update
Despite the dismal mood on Wall Street, Gilead’s buyout offer for Pharmasset at a hefty premium was enough to propel the Nasdaq Biotech Index back in the black. And the buyout gave the Contest a new king!
At Friday’s close, the NBI was up 2.30% YTD (vs. down -1.23% YTD a week ago) and the Contest median was down -12.32% YTD (vs. down -9.49% YTD a week ago). The Nasdaq Composite Index was down -7.97% YTD (vs. down -3.03% YTD a week ago).
Strapped to the VRUS rocket, MCBIO’s portfolio (up 59.40% YTD) blasted into the Contest lead, with JIBAC’s portfolio (up 49.15% YTD) now in second place and ROCKY’s’s portfolio (up 33.90% YTD) holding on to third place.
At Friday's close, a mere 9 of the 38 Contest portfolios were in the black, while the same 9 were beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: None
Have a terrific weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)

			11/25/11	
Rank Name Profit/Loss
1 MCBIO 59,402
2 JIBAC 49,153
3 ROCKY 33,901
4 FIB 21,854
5 RRGE 16,751
6 GENE 15,725
7 JULIUS 7,473
8 IJF 3,482
9 WILDER 2,906
10 BIOFISH -1,963

Week's Top 5 Gainers
Symbol 11/18 11/25 % change
VRUS 72.67 133.17 83.25%
LPTN.OB 0.91 1.15 26.37%
ABLX.BR 2.25 2.45 8.89%
REGN 49.81 53.78 7.97%
CBPO 7.03 7.49 6.54%

Week's Top 5 Losers
Symbol 11/18 11/25 % change
ROSG 0.42 0.22 -47.62%
NRGXE.OB 0.14 0.09 -35.71%
FOLD 2.77 2.10 -24.19%
YMI 1.65 1.35 -18.18%
PGNX 6.09 5.03 -17.41%